
Am J Psychiatry 155:207-213, February 1998
© 1998 American Psychiatric Association
Cocaine, Ethanol, and Genotype Effects on Human Midbrain Serotonin Transporter Binding Sites and mRNA Levels
Karley Y. Little, M.D.,
Daniel P. McLaughlin, Ph.D.,
Lian Zhang, Ph.D.,
Cynthia S. Livermore, M.S.W.,
Gregory W. Dalack, M.D.,
Patrick R. McFinton, B.S.,
Zachary S. DelProposto, B.S.,
Elizabeth Hill, Ph.D.,
Bader J. Cassin, M.D.,
Stanley J. Watson, Ph.D., M.D., and
Edwin H. Cook, M.D.
OBJECTIVE: Earlier platelet and postmortem brain studies have found alterations in serotonin transporter function in ethanol-abusing human subjects. The present investigation tested the hypothesis that brain serotonin transporter function is altered in chronic users of ethanol and cocaine, which might be related to a common serotonin transporter promoter polymorphism. METHOD: Serotonin transporter binding sites, serotonin transporter mRNA levels, and serotonin transporter promoter variants were quantified in postmortem samples from a group of human subjects who had been ethanol users or cocaine users and then compared to those of a matched group of comparison subjects. Quantitative autoradiographic and in situ hybridization assays were performed in midbrain samples that contained the dorsal and median raphe nuclei (the location of serotonin cell bodies that innervate the forebrain). RESULTS: There was a significant overall cocaine-by-ethanol-by-genotype interaction. Dorsal raphe [125I]CIT binding to the serotonin transporter was lower in cocaine users than in comparison subjects. In addition, serotonin transporter binding and serotonin transporter mRNA levels varied significantly by genotype. It was also found that serotonin transporter binding in subjects with either the short or heterozygote genotype was significantly higher in the ethanol-user subjects. CONCLUSIONS: Serotonin transporter binding sites were regulated in a region-specific and substance-specific pattern, which was not simply a local response to functional blockade. Also, a reciprocal relationship appeared to exist between cocaine and ethanol effects in the dorsal raphe, which may have interesting clinical implications for dual-diagnosis patients. It is possible that serotonin transporter promoter genotype may play a complex role in chronic ethanol dependence. (Am J Psychiatry 1998; 155:207213)
This article has been cited by other articles:

|
 |

|
 |
 
K. C. O'Reilly, S. Trent, S. J. Bailey, and M. A. Lane
13-cis-Retinoic Acid Alters Intracellular Serotonin, Increases 5-HT1A Receptor, and Serotonin Reuptake Transporter Levels In Vitro
Experimental Biology and Medicine,
October 1, 2007;
232(9):
1195 - 1203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-Z. Hu, A. J. Rush, D. Charney, A. F. Wilson, A. J. M. Sorant, G. J. Papanicolaou, M. Fava, M. H. Trivedi, S. R. Wisniewski, G. Laje, et al.
Association Between a Functional Serotonin Transporter Promoter Polymorphism and Citalopram Treatment in Adult Outpatients With Major Depression
Arch Gen Psychiatry,
July 1, 2007;
64(7):
783 - 792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Wassink, H. C. Hazlett, E. A. Epping, S. Arndt, S. R. Dager, G. D. Schellenberg, G. Dawson, and J. Piven
Cerebral Cortical Gray Matter Overgrowth and Functional Variation of the Serotonin Transporter Gene in Autism
Arch Gen Psychiatry,
June 1, 2007;
64(6):
709 - 717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Jennings, M. K. Loder, W. J. Sheward, Q. Pei, R. M. J. Deacon, M. A. Benson, H. J. Olverman, N. D. Hastie, A. J. Harmar, S. Shen, et al.
Increased Expression of the 5-HT Transporter Confers a Low- Anxiety Phenotype Linked to Decreased 5-HT Transmission.
J. Neurosci.,
August 30, 2006;
26(35):
8955 - 8964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Goldman, G. Oroszi, and F. Ducci
The Genetics of Addictions: Uncovering the Genes
Focus,
August 1, 2006;
4(3):
401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Reneman, T. Schilt, M. M. de Win, J. Booij, B. Schmand, W. v. den Brink, and O. Bakker
Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users
J Psychopharmacol,
May 1, 2006;
20(3):
389 - 399.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Kreek, G. Bart, C. Lilly, K. S. Laforge, and D. A. Nielsen
Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
Pharmacol. Rev.,
March 1, 2005;
57(1):
1 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Yeo, P Boyd, S Lumsden, T Saunders, A Handley, M Stubbins, A Knaggs, S Asquith, I Taylor, B Bahari, et al.
Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women
Gut,
October 1, 2004;
53(10):
1452 - 1458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Murphy, A. Lerner, G. Rudnick, and K.-P. Lesch
Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics
Mol. Interv.,
April 1, 2004;
4(2):
109 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. van Dyck, R. T. Malison, J. K. Staley, L. K. Jacobsen, J. P. Seibyl, M. Laruelle, R. M. Baldwin, R. B. Innis, and J. Gelernter
Central Serotonin Transporter Availability Measured With [123I]{beta}-CIT SPECT in Relation to Serotonin Transporter Genotype
Am J Psychiatry,
March 1, 2004;
161(3):
525 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Jacob, A. Strobel, K. Hohenberger, T. Ringel, L. Gutknecht, A. Reif, B. Brocke, and K.P. Lesch
Association Between Allelic Variation of Serotonin Transporter Function and Neuroticism in Anxious Cluster C Personality Disorders
Am J Psychiatry,
March 1, 2004;
161(3):
569 - 572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Hariri, V. S. Mattay, A. Tessitore, B. Kolachana, F. Fera, D. Goldman, M. F. Egan, and D. R. Weinberger
Serotonin Transporter Genetic Variation and the Response of the Human Amygdala
Science,
July 19, 2002;
297(5580):
400 - 403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Neumeister, A. Konstantinidis, J. Stastny, M. J. Schwarz, O. Vitouch, M. Willeit, N. Praschak-Rieder, J. Zach, M. de Zwaan, B. Bondy, et al.
Association Between Serotonin Transporter Gene Promoter Polymorphism (5HTTLPR) and Behavioral Responses to Tryptophan Depletion in Healthy Women With and Without Family History of Depression
Arch Gen Psychiatry,
July 1, 2002;
59(7):
613 - 620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Blakely
Physiological Genomics of Antidepressant Targets: Keeping the Periphery in Mind
J. Neurosci.,
November 1, 2001;
21(21):
8319 - 8323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Sukonick, B. G. Pollock, R. A. Sweet, B. H. Mulsant, J. Rosen, W. E. Klunk, K. B. Kastango, S. T. DeKosky, and R. E. Ferrell
The 5-HTTPR*S/*L Polymorphism and Aggressive Behavior in Alzheimer Disease
Arch Neurol,
September 1, 2001;
58(9):
1425 - 1428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lichtermann, D. Hranilovic, M. Trixler, P. Franke, B. Jernej, C. D. Delmo, M. Knapp, S. G. Schwab, W. Maier, and D. B. Wildenauer
Support for Allelic Association of a Polymorphic Site in the Promoter Region of the Serotonin Transporter Gene With Risk for Alcohol Dependence
Am J Psychiatry,
December 1, 2000;
157(12):
2045 - 2047.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. K. Jacobsen, J. K. Staley, S. S. Zoghbi, J. P. Seibyl, T. R. Kosten, R. B. Innis, and J. Gelernter
Prediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report
Am J Psychiatry,
October 1, 2000;
157(10):
1700 - 1703.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. A. Johnson, J. D. Roache, M. A. Javors, C. C. DiClemente, C. R. Cloninger, T. J. Prihoda, P. S. Bordnick, N. Ait-Daoud, and J. Hensler
Ondansetron for Reduction of Drinking Among Biologically Predisposed Alcoholic Patients: A Randomized Controlled Trial
JAMA,
August 23, 2000;
284(8):
963 - 971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Mann, Y.-y. Huang, M. D. Underwood, S. A. Kassir, S. Oppenheim, T. M. Kelly, A. J. Dwork, and V. Arango
A Serotonin Transporter Gene Promoter Polymorphism (5-HTTLPR) and Prefrontal Cortical Binding in Major Depression and Suicide
Arch Gen Psychiatry,
August 1, 2000;
57(8):
729 - 738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cook Jr.
Genetics of Psychiatric Disorders: Where Have We Been and Where Are We Going?
Am J Psychiatry,
July 1, 2000;
157(7):
1039 - 1040.
[Full Text]
|
 |
|

|
 |

|
 |
 
L. K. Jacobsen, J. K. Staley, R. T. Malison, S. S. Zoghbi, J. P. Seibyl, T. R. Kosten, and R. B. Innis
Elevated Central Serotonin Transporter Binding Availability in Acutely Abstinent Cocaine-Dependent Patients
Am J Psychiatry,
July 1, 2000;
157(7):
1134 - 1140.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Benedetti, A. Serretti, C. Colombo, E. Campori, B. Barbini, D. di Bella, and E. Smeraldi
Influence of a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene on the Effects of Total Sleep Deprivation in Bipolar Depression
Am J Psychiatry,
September 1, 1999;
156(9):
1450 - 1452.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Ramamoorthy and R. D. Blakely
Phosphorylation and Sequestration of Serotonin Transporters Differentially Modulated by Psychostimulants
Science,
July 30, 1999;
285(5428):
763 - 766.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. R. SMITH, J. B. DAUNAIS, M. A. NADER, and L. J. PORRINO
Distribution of [3H]Citalopram Binding Sites in the Nonhuman Primate Brain
Ann. N.Y. Acad. Sci.,
June 29, 1999;
877(1):
700 - 702.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Y. Little, L. Zhang, T. Desmond, K. A. Frey, G. W. Dalack, and B. J. Cassin
Striatal Dopaminergic Abnormalities in Human Cocaine Users
Am J Psychiatry,
February 1, 1999;
156(2):
238 - 245.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Y. Little, D. P. McLaughlin, L. Zhang, P. R. McFinton, G. W. Dalack, E. H. Cook Jr, B. J. Cassin, and S. J. Watson
Brain Dopamine Transporter Messenger RNA and Binding Sites in Cocaine Users: A Postmortem Study
Arch Gen Psychiatry,
September 1, 1998;
55(9):
793 - 799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Addiction as a Brain Disease
Am J Psychiatry,
June 1, 1998;
155(6):
711 - 713.
[Full Text]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1998
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|